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Hamster-to-Rat Liver Xenografts Protect Extrahepatic Organs 
From Rejection 
L.A. Valdivia, A.J. Demetris, J.J. Fung, S. Celli, C. Frye, N. Murase, and T.E. Starzl 
THE liver allograft is relatively resistant to the hyper-
acute rejection caused by preformed antibodies, I and 
in some species and strain combinations it is accepted 
without immunosuppression. 2•3 We have shown a similar 
resistance of the liver to humoral rejection after hamster to 
rat xenotransplantation. 4•5 Moreover. it has been shown 
that the liver allograft can induce tolerance to other organs 
from the same donor strain2 and that it also can shield 
these organs from hyperacute rejection in a presensitized 
recipient. 6 Thus. in this study we tested if hamster livers 
previously transplanted under FK 506 would ameliorate 
the otherwise intractable rejection of hamster heart and 
skin xenografts in rats. 
MATERIALS AND METHODS 
Golden Syrian hamsters were the donors and Lewis rats the 
recipients. Liver transplants were orthotopic and heart trans-
plants were heterotopic. 
Experimental Design 
Lewis rats bearing hamster livers for 40 to 50 days under daily I 
mg/kg/d FK 506 had their immunosuppression stopped for 2 
weeks on the day of skin or cardiac transplantation from third 
party (outbredl hamsters or from C3H mice. To study donor 
specificity, five Lewis rats were given two skin grafts on the day 
of liver transplantation under FK 506. one from the liver donor, 
and the other from a third party hamster. 
Serum Transfer 
Lewis rats were transplanted with hamster heans and given serum 
from untreated or FK 506-treated liver xenograft recipients on day 
6 or more than 50 days after hepatic grafting (0.5 mUd x 4. IV). 
Adoptive Cell Transfer 
Lewis rats (n = 5 per group) were sublethally irradiated with 7.5 
Gy and transferred with lymph node cells (LNCs, 5 x 107) from 
naive Lewis. liver xenotransplanted Lewis rats, or a combination 
of both. Then, they received hamster and C3H mice skin grafts on 
their chest. 
Mixed Lymphocyte Reaction (MLR) 
LNCs from unmodified Lewis rats or those obtained from liver 
xenograft recipients on day 40 to 50 after transplantation were 
used as responders (1.75 x UP/well), while LNCs from hamster. 
ACI rat, or C3H mice (2.9 x HP/well) were used as stimulators. 
RESULTS 
Daily treatment of Lewis rats with FK 506 prolonged the 
mean survival of hamster liver xenografts from 7 to 67 
days, but extended the 6-day control survival of skin grafts 
by only 3 days, and had no effect on the survival of heart 
xenografts. which underwent antibody-mediated rejection 
after 3 days with or without FK 506. In contrast. when 
hamster heart or skin grafts were transplanted at the same 
time as FK 506 was discontinued in rats already bearing 
hamster livers for 40 to 50 days, they were accepted for the 
ensuing 2 weeks of no treatment and thereafter with 
resumption of therapy (hearts: 63.0 ± 23.4 days; skin 
grafts: 75.7 ± 29.9 days). Under the same conditions. C3H 
mouse heart and skin xenografts were promptly rejected 
(2.7 ± 0.5 days and 10.5 ± 1.2 days, respectively). To 
assess the effect of residual immunosuppression, control 
Lewis rats without liver transplantation were pretreated 
for 30 days with 1 mglkgld FK 506 before test heart or skin 
xenografting, after which no treatment was given. When 
transplanted alone. survival of the hamster skin was pro-
longed an average of 3.0 days by the 30 days pretreatment 
but survival of the heart xenografts was the same as in the 
untreated controls. Mouse skin but not mouse hearts also 
had slight prolongation of survival after recipient pretreat-
ment. In the experiments designed to test donor specificity 
both the skin grafts from the liver donor and from a third 
party hamster transplanted on the day of liver grafting had 
prolonged survival, being alive as long as the recipients 
lived (a mean of 73 and 69 days, respectively). 
Serum transfer experiments showed no prolongation of 
test heart xenografts by any of the given sera, with all 
groups rejecting in a mean of 3 days. Adoptive transfer 
experiments showed that when cells from liver xenograft 
recipients were transferred hamster skin grafts were re-
jected in a mean of 15 days, which was similar as radiation 
controls (16 days). However, rejection of C3H mice skin 
grafts occurred in 9 days. as with transfer of naive rat cells. 
The proliferative response of the liver xenograft recipients 
was reduced to 50% against hamster and C3H mice LNCs, 
but that against ACI rat LNCs was normal. 
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DISCUSSION 
This study has shown that the immunologic privilege of the 
liver in the hamster to rat xenograft model is qualitatively 
similar to that in hepatic allotransplantation models. Sev-
eral explanations have been given to explain the liver's 
relative ability to withstand an antibody attack7 including 
the protection to its microvasculature provided by a dou-
ble blood supply, its large microvascular surface available 
for antibody absorption, and secretion of new soluble class 
I antigens or IgG types thanheoretically could neutralize 
preformed antigraft antibodies. We could not find evidence 
for the presence of enhancing serum factors or suppressor 
cells in our model. We found a state of unresponsiveness in 
vivo and hyporesponsiveness in vitro. 
It is known that the Kupffer cells and macrophages 
lining the sinusoids are replaced in all successful hepatic 
grafts with recipient cells. 8 This same kind of repopulation 
has been found in long surviving hamster to rat liver and 
cardiac xenografts.9 There also is evidence that the den-
dritic and lymphoid cells leaving the graft migrate to and 
nest in widely distributed host lymphoid and other tis-
sues. 10 The extent to which the peripheralization of donor 
cells and consequent systemic microchimerism occur de-
pends on the immunologic substrate available in the donor 
organ for cell peripheralization; the liver is richly endowed 
with these cells. Thus, our conclusion is that the same 
explanation of the tolerogenicity of liver allografts applies 
415 
to xenografts. Achievement of cell repopulation requires 
potent immunosuppression with agents like FK 506 during 
the cell transition. In xenotransplant models, it also de-
pends on the avoidance of antibody rejection which is 
more easily accomplished with the liver than other organs. 
This is the first demonstration of such hepatic tolerogenic-
ity in a xenograft model. 
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